Hi there,

Our generous triple match has been extended, which means your donation to Democracy Now! today will be TRIPLED. If you give $10, we'll get $30 to support our independent journalism. Please don’t miss out on this opportunity to triple your impact. Democracy Now! is a free source of independent news for tens of millions of people around the world, but less than 1% of our global audience donates to support our critical reporting. Let’s pick up the percentage! We rely on you for support—not the oil, gas, coal and nuclear companies when we cover the climate crisis or the weapons manufacturers when we cover war. I hope you’ll give as much as you can today. Every dollar makes a difference. Thanks so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


FDA Grants Emergency Use to Boosters Targeting Coronavirus Variants

HeadlineSep 01, 2022

The Food and Drug Administration has authorized emergency use of two booster shots designed to better protect against widely circulating variants of the coronavirus. The vaccines produced by Pfizer and Moderna are nearly identical to mRNA shots that were first authorized for use in the U.S. in December of 2020, but the new formulations target the BA.4 and BA.5 Omicron subvariants that currently account for nearly all U.S. COVID cases. Vaccine experts say the new boosters remain safe, but it’s far less clear how effective they’ll be. Data submitted by Pfizer and Moderna to the FDA relies on studies in mice, and there’s currently no clinical trial data studying the boosters’ efficacy in humans. A CDC panel of vaccine experts meets today to discuss the boosters. If the agency approves them, as expected, shots will be available, free of charge, at pharmacies, doctors’ offices and community health centers just after the Labor Day weekend.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation